COMPANY PROFILE

AITRICS

Utilizes state-of-the-art machine learning technologies with evidence-based expert analysis to provide real-time clinical insights, capable of transforming reactive disease care to care that is…

Seoul, South KoreaFounded 2017Health Tech & Medtech

Valuation $0–100M Latest valuation · 2025

Revenue $1–10M Latest reported FY

Headcount 100–500 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About AITRICS

AITRICS is a medical software company that has developed AITRICS-VC, a solution that utilizes artificial intelligence to predict the risk of sepsis in hospital patients. By analyzing data from electronic medical records (EMRs), the software can forecast the likelihood of a patient developing this life-threatening condition within the next four hours, as well as predict the chances of mortality in intensive care unit patients within the next six hours.

Read full description

The company's primary clients are hospitals and healthcare providers, and it operates within the digital healthcare and medical technology markets. AITRICS's business model is based on providing its software as a service (SaaS) to these institutions, generating revenue through licensing fees and subscriptions. The company has a strong focus on research and development, with a team of machine learning engineers and medical professionals working to improve the accuracy and capabilities of its predictive models.

Source: Dealroom company data